1993•Cancer Chemotherapy and PharmacologyRequires access

Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines

Andreas Harstrick, Carsten Bokemeyer, Martin Scharnofkse, Gunnar Hapke, Dagmar Reile, Hans‐Joachim Schmoll

Open publisher page 53 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 53 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Cisplatin, Carboplatin, Cytotoxicity, Cell culture, Chemistry, Cancer research, In vivo, Ovarian carcinoma

Back to paper search Browse research topics Original source

Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines — Research Paper | ScholarLens